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Abstract: Metal release from total hip replacements (THRs) is associated with aseptic loosening
(AL). It has been proposed that the underlying immunological response is caused by a delayed
type IV hypersensitivity-like reaction to metals, i.e., metal allergy. The purpose of this study was
to investigate the immunological response in patients with AL in relation to metal release and the
prevalence of metal allergy. THR patients undergoing revision surgery due to AL or mechanical
implant failures were included in the study along with a control group consisting of primary THR
patients. Comprehensive cytokine analyses were performed on serum and periimplant tissue samples
along with metal analysis using inductive coupled plasma mass spectrometry (ICP-MS). Patient
patch testing was done with a series of metals related to orthopedic implant. A distinct cytokine
profile was found in the periimplant tissue of patients with AL. Significantly increased levels of the
proinflammatory cytokines IL-1β, IL-2, IL-8, IFN-γ and TNF-α, but also the anti-inflammatory IL-10
were detected. A general increase of metal concentrations in the periimplant tissue was observed in
both revision groups, while Cr was significantly increased in patient serum with AL. No difference in
the prevalence of metal sensitivity was established by patch testing. Increased levels of IL-1β, IL-8,
and TNF-α point to an innate immune response. However, the presence of IL-2 and IFN-γ indicates
additional involvement of T cell-mediated response in patients with AL, although this could not be
detected by patch testing.
Keywords: arthroplasty; replacement; hip; hypersensitivity; contact; allergy and immunology;
cytokines; Interleukin-8
1. Introduction
1.1. Background
Aseptic loosening (AL) of implants is the most common reason for revision surgeries in patients
with total hip replacements (THRs), representing close to 75% of all cases, with serious consequences for
patients and healthcare systems [1,2]. Although the etiology of AL is multifactorial and yet to be fully
understood, evidence suggest that the predominant cause of AL is due to a macrophage-driven chronic
inflammatory response initiated by implant wear [1,3–5]. This adverse tissue reaction is associated
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with the innate immune system and can lead to the bone degrading state of osteolysis, subsequently
resulting in implant failure by AL.
Cytokines are small messenger molecules that coordinate the immune response by regulating
inflammation and modulating cellular activities such as growth, differentiation and survival [6]. Key
mediators of osteolysis have been identified as pro-inflammatory cytokines like interleukin (IL)-1β, IL-6,
IL-8 and tumor necrosis factor (TNF)-α secreted by activated macrophages. In turn, these cytokines
are capable of inducing the differentiation of osteoclast precursor cells into mature, bone resorbing,
osteoclasts [1,7–11]. Interferon (IFN)-γ is another important immune regulatory cytokine implicated in
bone resorption but also in inflammation progression and cell mediated immunity [12,13].
Macrophages have been established as important mediators of ostolysis, but several other cell
types have also been identified in the periimplant tissue of failed implants, including lymphocytic
T cells [9,14–16]. T helper (Th) cells, a subtype of T cells, are important regulators of macrophage
function and the adaptive immune response, which given rise to the concept of implant-related metal
sensitivity. This concept is evolved around a delayed type IV T cell mediated hypersensitivity (DTH),
exemplified by allergic contact dermatitis to metal ions (metal allergy). Due to their small size, metal
ions are considered to be incomplete antigens, referred to as haptens, and must interact with peptides
or proteins to form an antigen able to mount DTH.
In support of the concept above, findings of elevated levels of metal particles and ions have been
shown to correlate with an increased prevalence of metal allergy in patients with failing implants [17–21].
Furthermore, some of the most commonly applied alloys for THR like stainless steel (FeCrNiMo),
cobalt chromium (CoCrMo) and titanium alloys (Ti6Al4V) contain known sensitizing metals [22].
Immunological studies of AL in THRs, have suggested the involvement of a Th1 cell response,
crucial for DTH, due to increased levels of Th1 cell specific cytokines like IFN-γ and IL-2 [4,23]. Previous
studies also suggest the involvement of a Th2 and Th17 cell response in AL, which are respectively
characterized by the production of IL-4, IL-17 and granulocyte-macrophage colony-stimulating factor
(GM-CSF) [24–26]. However, the causal relationship between immune reactions, metal release from
implants, and AL is still uncertain.
1.2. Aim
The aim of the present study was to determine and compare levels of THR relevant metals and
cytokine profiles from periimplant tissue and blood serum, and to investigate the prevalence of metal
allergy in patients undergoing revision surgery due AL, mechanical failure or undergoing primary THR
surgery. Periimplant tissue obtained from patients with AL showed a significantly different cytokine
profile suggesting the involvement of both innate and adaptive immunity in AL. No prevalence of
metal allergy was established in patients with failed implants despite elevated levels of metal ions in
the periimplant tissue.
2. Experimental Section
2.1. Patients and Samples
We conducted a prospective case study including three patient groups. This study was approved by
the Central Denmark Region Committee on Biomedical Research Ethics (Journal number: 1-10-72-90-13).
All patients gave their written informed consent before entering the study.
Criteria for inclusion in the AL (+) group were: revision (entirely or partial) due to aseptic
loosening, osteolysis, or unexplainable pain that could not be treated conservatively. The AL (−) group;
revision (entirely or partial) due to fracture, dislocation, or component failure. The Control group;
patients received a primary THR. Implant components are listed in Table 1.
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Table 1. Implant overview. Implant types and materials used for femoral, head, liner and acetabular
components are given for patients in the revision groups. In addition to the implant bulk material,
model names and surface finish is also listed. cpTi relates to commercially pure titanium and PS to
plasma sprayed coatings. FeCrNiMn is also referred to as Orthinox stainless steel.
Patient # Type Femoral Head Liner Acetabular
1 AL (+) MoP Ti-6Al-4V, ZMR®, uncemented,porous coating CoCrMo PE
Ti-6Al-4V, Trilogy®,
uncommented, cpTi fiber mesh.
2 AL (+) MoP FeCrNiMn, Exeter®, cemented,polished. CoCrMo PE
cpTi, Duraloc®, uncemented,
porous coating.
3 AL (+) MoP CoCrMo, Lubinus®,cemented polished. CoCrMo PE
PE, Lubinus®, cemented,
all-polycup
4 AL (+) MoP FeCrNiM, Exeter®,cemented, polished. CoCrMo PE
Ti-6Al-4V, Mallory Head,
uncemented, PS.
5 AL (+) MoP Ti-6Al-4V, Bi-metric®,uncemented, grit blasted. CoCrMo PE
Ti-6Al-4V, Mallory®Head,
uncemented, PS.
6 AL (+) MoM Ti-6Al-4V, Bi-metric®,uncemented, grit blasted. CoCrMo CoCrMo
CoCrMo, ReCap®, uncemented,
cpTI PS.
1 AL (−) MoP Ti-6Al-7Nb, CLS spotorno®,uncemented, grit blasted. CoCrMo PE
Ti-6Al-4V, Trilogy®,
uncemented, cpTi fiber mesh.
2 AL (−) MoP Ti-6Al-7Nb, CLS spotorno®,uncemented, grit blasted. CoCrMo PE
Ti-6Al-4V, Trilogy®,
uncemented, cpTi fiber mesh.
3 AL (−) CoP Ti-6Al-4V, Biocontact®,uncemented, grit blasted. Ceramic PE
Ti-6Al-4V, Plasmacup®,
uncemented, plasmapore PS.
4 AL (−) MoP FeCrNiMn, Exeter®, cemented,polished. CoCrMo PE
cpTi, Pinnacle®, uncemented
porocoat, porous coating.
5 AL (−) MoP FeCrNiMn, Exeter®, cemented,polished CoCrMo PE
Ti-6Al-4V, Trilogy®,
uncemented, cpTi fiber mesh.
6 AL (−) MoP FeCrNiMn, Exeter®, cemented,polished CoCrMo PE
cpTi, Pinnacle®, uncemented
porocoat, porous coating.
Criteria for exclusion: infection (positive Kamme-Lindberg biopsies [27]), use of immunomodulating
medication, occupational metal exposure, known metal allergies towards implanted metals or secondary
osteoarthritis (fracture, inflammation). The mean age for the AL (+) group was 60.8 years with a gender
distribution of 4/2 (M/W). For the AL (−) group, the mean age was 73 years, and the distribution was 4/2
(M/W). The control group had a mean age of 62 years and a distribution of 5/3 (M/W). Tissue samples
for cytokine and ICP-MS analysis were snap-frozen in liquid nitrogen and stored at −80 ◦C for later use.
Serum obtained from patients blood samples were taken before the operation and stored at −80 ◦C for
later cytokine and ICP-MS analysis.
2.2. Cytokine Profile Analysis
Snap frozen tissue samples from group AL (+), group AL (−) and the control group were
mechanically disrupted and homogenized (Precellys®24 and Cryolys®—Bertin Technologies, Bie &
Berntsen A/S 2730, Herlev, Denmark) at 4 ◦C for 4 × 20 s in lysis buffer containing protease inhibitor
cocktail (REF 11836145001, Roche Diagnostics, Indianapolis, IN, USA). Homogenized tissue samples
were then spun for 10 min at 10,000 × G at 4 ◦C (Microcentrifuge 157MP—Ole Dich Instrumentmakers
ApS, Hvidovre, Denmark) and the protein concentration in the supernatant was estimated by Bradford
protein assay [28] using Coomassie blue (#1610436. Bio-Rad Laboratories, Inc., Hercules, CA, USA).
Prior to cytokine analysis, total protein concentrations of the samples were adjusted to 0.5 mg/mL.
Cytokine analysis was performed using a validated V-PLEX electrochemiluminescence immunoassays
(Meso Scale Discovery, Rockville, MD, USA). A total of 11 cytokines divided on two separate kits were
analyzed. Proinflammatory Panel 1 contained; IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IFN-γ and TNF-α
(catalog # K15049D-1), and cytokine panel 1 kit contained; IL-15, IL-17A, GM-CSF (catalog # K15050D-1).
Samples were analyzed in triplicates (MESO QuickPlex SQ 120—Meso Scale Discovery). Calibration
curves used to calculate cytokine concentrations were established by fitting to a 4 parameters logistic
model with a 1/Y2 weighting. Cytokine concentrations were calculated using the Discovery workbench
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4.0.12 software (Meso Scale Discovery). Serum samples were analyzed undiluted using the same
cytokine kits as used for the tissue.
2.3. Patch Testing
A special patch test series, provided by Smart Practice®(Phoenix, AZ, USA), was used in this
study. The patch contained prefabricated panels with metallic compounds associated with orthopedic
prostheses on Scanpor tape. Standard metal allergens included; nickel (II) sulphate NiSO4 (1.0 wt.%),
potassium dichromate (VI) K2Cr2O7 (0.054 wt.%) and cobalt (II) chloride CoCl2 (0.02 wt.%). In addition,
a customized panel with the following metals and corresponding titrations were included; vanadium
(IV) oxide sulfate hydrate VOSO4·H2O (0.36, 0.18, 0.06, 0.02 wt.%), vanadium (III) chloride VCl3 (0.24,
0.12, 0.013, 0.04 wt.%), manganese (II) chloride MnCl2·4H2O (0.24, 0.08, 0.06, 0.0057 wt.%), aluminum
(III) chloride AlCl3·6H2O (0.72, 0.38, 0.039 wt.%), ammonium molybdate (VI) (NH4)6Mo7O24 4H2O
(0.12, 0.013, 0.04 wt.%), titanium (IV) oxalate hydrate TiC4O8·H2O (0.32, 0.16, 0.08, 0.04 wt.%), titanium
(IV) dioxide TiO2 (0.24 wt.%), potassium titanium (II) oxide oxalate C4K2O9Ti·2H2O (2.4, 1.2, 0.6 wt.%),
ammonium titanium (II) lactate, solution Ti [(C3H4O3)2(NH4OH)2] (0.16, 0.08, 0.04 wt.%), ammonium
titanium (IV) peroxocitrate (NH4)4[Ti2(C6H4O7)2(O2)2]·4H2O (0.32, 0.16, 0.08, 0.04 wt.%). methyl
methacrylate C5H8O2 (2 wt.%), gentamycin sulfate (20 wt.%) and ferrous chloride FeCl2 (2 wt.%) were
tested by manually loading of a Finn chamber on Scanpor tape. Patches were applied on the upper back
and were occluded for 48 h. Readings were completed 96 h after application [29]. The patients were
instructed to remove the panels after 48 h, and not to shower, scratch or expose to sunlight. Reactions
were scored using the International Contact Dermatitis Research Group’s (ICDRG) criteria [30]. Only
definite +1, +2 and +3 reactions were regarded as positive.
2.4. ICP-MS (Serum)
Blood samples were sent to Vejle Hospital, Department of Clinical Biochemistry, Denmark, for
determination of chromium and cobalt levels before the surgery. The samples were analyzed by
ICP-MS instrument (iCAPq, Thermo Fisher Scientific Inc., Waltham, MA, USA). The samples were
diluted with 0.5% HNO3, gallium was added as an internal standard prior to analysis. The detection
limit was 10 nmol/L equivalent to 0.59 ppb (cobalt) and 0.52 ppb (chromium).
2.5. ICP-MS (Tissue and Serum)
Elemental analysis of tissues and titanium (Ti) analysis of blood was performed at the National
Food Institute at the Technical University of Denmark.
Elemental analysis in tissues: Tissue samples (0.1–0.5 g) were digested with a mixture of concentrated
nitric acid (4 mL; PlasmaPure, SCPScience, Courtaboeuf, France) and hydrogenperoxide (1 mL;
Merck, Darmstadt, Germany) in a microwave oven (Multiwave 3000, Anton Paar, Graz, Austria).
The concentration of aluminum (Al), vanadium (V), chromium (Cr), cobalt (Co) and nickel (Ni) was
determined using ICPMS (iCAPq, Thermo Fisher Scientific, Waltham, MA, USA) using rhodium as
an internal standard and external calibration. The ICPMS instrument was run in the kinetic energy
discrimination (KED) mode using helium as a collision cell gas. The limit of detection was estimated at
100 µg/kg for all elements.
Determination of Ti in tissue and blood: The acid digests of tissues were also subjected to Ti analysis.
Serum subsamples (200 µL) were diluted with 4.8 mL diluent solution consisting of 0.5% Triton X-100,
10% ethanol (both Merck) and 1% nitric acid (SCPScience) prior to the analysis of the concentration of
Ti using a triple quadrupole ICPMS (Agilent 8800 ICP-QQQ, Agilent Technologies, Yokogawa, Japan)
and using ammonia as a cell gas with determination of Ti after MS/MS mass shift from m/z 48 ≥ m/z 150
with scandium (Sc) as internal standard and external calibration. The data quality of Ti analysis was
assessed by the analysis of the reference material Seronorm (Sero, Oslo, Norway). The obtained value
7.2 µg/L was in good agreement with the reference value 6.8 µg/L. The limit of detection was estimated
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at 1 µg/L in serum samples and 20 µg/kg in tissues. All calibration standards and internal standards
were produced from certified single-element stock solutions (SCPScience).
2.6. Statistical Analysis
For group comparison the Kruskal-Wallis test was used, and if statistically significant,
the Mann-Whitney U test was used to compare between individual groups. By convention, to calculate
group medians, metal concentrations below the detection limit were assigned a value of one-half the
detection limit. Comparisons were made using the Mann-Whitney test. Contingency tables (patch test)
were analyzed using Fisher’s exact test. A significance level of p < 0.05 was considered statistically
significant. Matlab R2014a (8.3.0.532) with statistical toolbox (MathWorks Inc. Natick, MA, USA) was
used for statistical analysis. For graphical representation Prism 6.0 (GraphPad Software, San Diego,
CA, USA) was used.
3. Results
3.1. Cytokine Profile Analysis
3.1.1. Analysis of Cytokine Levels in Periimplant Tissue
Cytokine levels were measured in periimplant tissue obtained from revision or primary surgery
to identify a potential local immune response (Figure 1).
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showed a stati tically significant increase in the cytokine l vels when compared with the control gr up.
Out of the tatistically sig ificant cytokines, IL-4 and TNF-α did not show any statistical significance
(NS) when comparing the two revision groups. IL-8 was found to be highly increased in patients with
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Altogether, 10 cytokines (IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-15, IL-17A, IFN-γ and TNF-α) and
growth factor GM-CSF were analyzed (Figure 1a/b). We found a highly increased cytokine profile in
patients with AL, with a statistical significant increase of IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, GM-CSF,
IFN-γ and TNF-α when compared to the AL (+) and the control group. When compared to the AL (−)
group we found a statistically significant increase for all cytokines except from IL-4, IL-15, GM-CSF,
and TNF-α. Of note, IL-8 was highly increased and the most strongly associated cytokine with AL.
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3.1.2. Analysis of Cytokine Levels in Serum
An identical cytokine profile analysis was performed in serum to investigate a corresponding
systemic response (Figure 2). Cytokine levels in serum appeared 10–100 fold lower and although
IL-8 and IFN-γ seemed increased in the AL (+) group, no statistical differences could be established.
Together these results show a general increase of the investigated cytokine profile, in periimplant tissue
obtained from patients with AL, but also that cytokine levels in periimplant tissue are not necessarily
reflected in blood serum. Among other increased cytokines, IL-8 was established as the most potent
marker of AL.
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3.2. Patch Test
All patient groups were subjected to a comprehensive patch test containing orthopedically relevant
metals and methyl methacrylate, the monomer of poly (methyl methacrylate) (PMMA) used as bone
cement in THR (Table 2). Positive and doubtful reactions to these metals are summarized in Table 2.
No statistical significant differences between either of the groups could be established. Few positive
test reaction were observed even for the metals used in the standard series (Cr, Co and Ni), only one
reaction to Ni and one to Cr were observed in all three groups. However, three positive reactions for
Ti and two positive skin reactions to V were observed in the (AL+) group. In fact, the two positive
reactions to V were observed in the same patient who had a positive reaction to Cr (Figure 3).
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Table 2. Skin reactions. Positive (+) and doubtful (+?) skin reactions to different metals and methyl
methacrylate. Patch test reactions were scored using the International Contact Dermatitis Research
Group’s (ICDRG) criteria [30]. Only definite +1, +2 and +3 reactions were regarded as positive. No
reactions were categorized as +2 and +3 reactions in this study and only compounds with either positive
(+1) or doubtful (+?) reactions are listed in the table. Prevalence of positive reactions was tested against
the control group using Fisher’s exact test with two tailed p values. No statistical significant differences
were found.
AL (+) (n = 6) AL (−) (n = 6) Control (n = 8)
Reactions
Metal compound (concentration) + (+?) + (+?) + (+?)
Al(III), AlCl3 (0.72%) 0 (0) 0 (0) 0 (1)
Ti(IV), TiC4O8 (0.32%) 0 (0) 1 (0) 2 (0)
Ti(II), C4K2O9Ti (2.4%) 0 (0) 0 (0) 0 (0)
V(III), VCl3 (0.24%) 1 (2) 0 (3) 0 (3)
V(III), VCl3 (0.12%) 1 (0) 0 (1) 0 (3)
V(III), VCl3 (0.013%) 0 (0) 0 (1) 0 (0)
V(III), VCl3 (0.04%) 0 (0) 0 (1) 0 (0)
V(IV), VOSO4 (0.36%) 0 (1) 0 (1) 0 (2)
V(IV), VOSO4 (0.18%) 0 (1) 0 (1) 0 (0)
Cr(VI), K2Cr2O7 (0.054%) 1 (0) 0 (0) 0 (0)
Mn(II), MnCl2 (0.24%) 0 (1) 1 (2) 0 (2)
Ni(II), NiSO4 (5.0%) 0 (0) 0 (0) 1 (1)
Methyl Methacrylate, C5H8O2 (2%) 0 (0) 0 (0) 0 (1)
Total reactions 3 (4) 2 (8) 3 (12)
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Figure 3. Patch test. (A) Example of a positive (+) and a doubtful skin reactions (+?) to vanadium
and chro ium in a patient from the AL (+) group. (B) Enlarged photograph of the skin reaction
to vanadium.
3.3. I - alysis
3.3.1. Metal Concentrations in Periimplant Tissue
Periimplant tissue was analyzed for Al, Ti, V, Cr, Co and Ni by ICP-MS (Table 3). Raised median
concentrations of most metals could be observed in both revision groups, AL (+) and AL (−) as shown in
Table 3. Metals found at highest concentrations were, Al, Ti and Cr, although no statistically significant
differences could be established between the AL (+) and AL (−) group, however, a difference was
observed when compared to the control group. Despite the raised concentrations of Cr observed in the
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AL (+) group compared to the control group no statistical significant increase could be determined
(p = 0.074). These results clearly demonstrate the presence of metal release in the two revision groups.
Table 3. Elemental analysis. Metal concentrations (ppb) measured by ICP-MS in periimplant tissue
and blood serum. Titanium, chromium and cobalt were measured in blood serum. Values are
shown as group medians with interquartile range below. Statistics are based on medians using the
Wilcoxon-Mann-Whitney test with a significance level of 0.05. * Indicate significantly increased values
compared to the control group. Elemental analysis for Al, V and Ni was only carried out on tissue
samples and are therefore indicated as not available (N/A) for serum samples.
Metal
AL (+) n = 6 AL (−) n = 6 Control n = 10
Tissue Serum Tissue Serum Tissue Serum
Al 7186 *(1905–29,019) N/A
3407 *
(845–26,709) N/A
1258
(352–2615) N/A
Ti 1610 *(891–13,328)
0.65
(0.60–2.95)
12978 *
(588–47,078)
1.45
(0.60–3.98)
716.5
(504–1152)
0.60
(0.60–1.00)
V 210(128–920) N/A
381
(151–573) N/A
160
(133–209) N/A
Cr 3648(358–21,075)
0.98 *
(0.26–3.4)
499
(151–6235)
0.26
(0.26–0.26)
484
(184–1868)
0.26
(0.26–0.26)
Co 210(128–2724)
0.30
(0.30–1.93)
167
(118–2549)
0.30
(0.30–0.74)
160
(133–209)
0.30
(0.30–0.30)
Ni 772 *(355–2027) N/A
328
(151–1589) N/A
212
(162–326) N/A
3.3.2. Metal Concentrations in Serum
Serum samples were analyzed for Ti, Co and Cr by ICP-MS (Table 3). A statistical significant
increase of Cr concentrations in the AL (+) group was found, compared to the control group. No
statistical significant increase was observed between the two revision groups (p = 0.105). Nevertheless,
the highest concentrations of both Co and Cr was found in the AL (+) group. One patient in the control
group showed a high concentration of Ti and despite reanalysis, this sample still showed a high Ti
concentration, preventing it from being regarded as an outlier. All other Ti concentrations in the control
group were at the detection limit of the ICP-MS method. Furthermore, the results show that local metal
concentrations in the periimplant tissue can be highly increased compared to serum levels.
4. Discussion
The possibility of metal allergy leading to aseptic loosening has been debated in the literature for
many years [21,31–33]. Still, the long-term effect of internally released metals remains unknown and
so does the underlining immunological response lead to AL and implant failure [22]. In this study
we investigated the correlations between the immunological profile, metal allergy and metal released
from implants, in THR patients with AL.
We found that patients with AL had a cytokine profile with statistically significant increased levels
of the pro-inflammatory cytokines IL-1β, IL-6, and IL-8, but also Th1 associated cytokines, IL-2 and
IFN-γ, and the anti-inflammatory cytokine IL-10, when compared to patients with implant failures
due to mechanical causes. Despite a statistically significant and substantial metal exposure both locally
and systemically in THR patients, we were not able to prove any systemic effect by cytokine analysis
of serum or by positive patch testing. Based on the present study, a systemic effect cannot be ruled out
due to the low number of patients enrolled in this study. The findings are, however, in line with the
clinical observations, where the adverse effect to implants is predominantly observed locally rather
than systemically. A further limitation of this study was the clinical approach, where polyethylene
(PE) debris derived from the acetabular liner is most likely contributing the innate part of the cytokine
profile observed in the periimplant tissue.
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Cytokines play an important role in AL, not only as regulators of osteolysis, but also as important
identifiers of the occurring immune response. In our cytokine analysis we included IL-1β IL-2, IL-4,
IL-6, IL-8, IL-10, IL-15, IL-17A, GM-CSF, IFN-γ and TNF-α due to their implication in innate and
adaptive immunity and their function as osteolytic mediators (Figures 1 and 2). In addition to being
involved in the innate immune response, IL-1β, IL-6, IL-8, GM-CSF, and TNF-α have previously been
identified as mediators of osteolysis [14,34]. In accordance with these observations, we found elevated
levels of these cytokines in the periimplant tissue from the AL (+) group when compared to the control
group. When comparing the two revision groups, AL (+) and AL (−), no statistically significant
difference was seen for GM-CSF and TNF-α. However, levels of GM-CSF were very low and might
be considered without any biological effect. TNF-α is well-known as a strong inducer of osteolysis
and is the first proinflammatory cytokine produced in response to many wear particles and stimulates
macrophage production of IL-1β and IL-6 [35]. Although no statistically significance is seen for TNF-α
between the two revision groups, both IL-1β and IL-6 still showed a statistically significant increase in
the AL (+) group. In comparison, other investigators have found low levels of IL-1β and TNF-α in
periimplant tissue from patients with failed THRs due to osteolysis [36]. Moreover, they found that
IL-6 and IL-8 were consistent with failed implants, suggesting that IL-6 and IL-8 might be the primary
drivers of end-stage osteolysis, while IL-1β and TNF-α are critical mediators in the acute phase of
inflammation. Interestingly, these observations did indeed correspond well to our findings of IL-6 and
notably IL-8, which we found to be the strongest predictor of AL.
The main IL-8 secreting cells are macrophages, osteoblasts and osteoclasts. Studies have
shown that IL-8 holds multiple functions in AL and has been found to affect both neutrophils,
T cells, monocyte/macrophages and osteoclasts [37,38]. It has been demonstrated that wear particle
stimulation of osteoblasts and macrophages promotes IL-8 production, which in turn can lead to both
macrophage activation and induce phagocytosis [39]. Interleukin-8 also possess chemotactic properties
on neutrophils and T cells and could conceivably play a role in attracting such cells to the periimplant
tissue [37,40]. Moreover, IL-8 is shown to promote osteoclastogenesis and the formation of osteoclasts
that are capable of secreting IL-8 on their own. Thus, the high levels of IL-8 observed in patients with
AL is probably not only caused by an innate immune response but also in part by the osteolytic process
taking place in the patients with AL, which could explain the differences in IL-8 observed between the
AL (+) and the AL (−) group [40].
As indicators of DTH, IL-2 and IFN-γ levels were statistical significantly increased in the AL
(+) group compared to the AL (−), supporting the involvement of a Th1 cell response in AL. This is
consistent with other studies, showing lymphocyte reactivity to implant related metals and production
of Th1-specific cytokines (IFN-γ and IL-2), and even the generation of metal specific T cells [41,42].
Macrophages are capable of producing IFN-γ but abundant evidence suggests that T cells and natural
killer (NK) cells are the major sources of IFN-γ [3,43,44]. Accompanied by the increased levels of IL-2,
the increased IFN-γ levels found in patients with AL further support the involvement of a Th1 cell
response. Interferon-gamma possess both pro- and anti-inflammatory activities with the functional
outcome being dependent on secretion levels, pathogenesis and disease severity [13,44]. Some studies
show a protective effect of IFN-γ on osteolysis, possible by inhibiting the early differentiation of
osteoclasts, whereas others have shown that IFN-γ promotes osteoclast formation [13]. How IFN-γ
affects the progression of AL in this study is difficult to decipher but low levels of IFN-γ does not exert
the inhibitory effect on osteoclasts and seems to be limited to the early stage of osteoclast differentiation.
Furthermore, IFN-γ can promote osteoclast maturation in the late state of osteoclast formation leading
to a shift from the inhibitory effect towards a state of bone resorption [45].
In addition to the Th1 signature cytokines, we also observed an increase of IL-4, along with a
statistically significant increase of IL-10 when comparing the two revision groups.
Although the production of these cytokines are related to Th2 cells, IL-10 is also produced by
monocytes and regulatory T cells, acting as an anti-inflammatory cytokine, which could regulate
cell-mediated reactions involved in AL [46–48]. We were not able to detect any consistent cytokine
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profile at a systemic level in serum, underlining the difficulty of detecting AL based on the systemic
levels of cytokines. In fact, cytokines have a short half-life in serum due to their potent nature as
signaling molecules, which makes cytokines very challenging to use as biomarkers in serum [49].
In our analysis of Ti, Co and Cr in serum, we found a statistically significant increase of Cr in the
AL (+) group and Ti in the Al (−) group (Table 3). Furthermore, we did detect a correlation between
raised Ti concentrations in serum from patients with a stem component made from a Ti containing
alloy, which corresponds to the findings of other studies applying the ICP-MS method [50]. Metal
release, has previously been shown to increase in patients with poorly functioning implants [17]. From
a corrosion point of view, this could be explained by increased micro-motions of the implant leading
to fretting corrosion [20,51]. Fretting of the Ti6Al4V and the Orthinox SS alloys could contribute to
the statistically significant raise in Al, Ti, and Ni observed in the revision groups (Table 4) [52,53].
Highest concentrations of Co and Cr were detected in the AL (+) group. One patient in this group
had a MoM implant but no markedly increased in Co or Cr concentrations were detected in either
periimplant tissue or serum from this specific patient. Interestingly, relative low concentrations of
Co were found in tissue and blood samples compared to Cr concentrations. This observation has
previously been explained by a faster elimination of Co from both the tissue and blood than that of
Cr [54]. No upper limits are currently employed to describe critical metal release from implants, but an
upper limit of 7 ppb for Co and Cr in blood is often used as an action level for MoM implants [55].
Serum concentrations of this magnitude were not detected in this study. In general, our results confirm
previous metal concentrations reported in serum and periimplant tissue from patients with poorly
functioning implants [17]. A correlation between the metal content in periimplant tissue but not that
of serum has recently been made to a lymphocyte dominated response [56]. This emphasizes the
importance of the periimplant environment, in which we found highly raised metal concentrations.
Table 4. Alloy composition. Elemental composition of the different implant alloys found patient groups,
based on the ASTM international standard.
Implant Alloy CoCrMo ASTM-(F75)
Orthinox SS ASTM-
(F1586)
cpTi ASTM-
(F67)
Ti6Al7Nb ASTM-
(F1295)
Ti6Al4V
ASTM-(F136)
Element Composition, wt.%
Aluminum (Al) 0.10 - 0.03 5.50–6.50 5.5–6.50
Carbon (C) 0.35 0.08 0.08 0.08 0.08
Chromium (Cr) 27–30 19.5–22 - - -
Cobalt (Co) Balance - - - -
Copper (Cu) - 0.25 0.10 - -
Iron (Fe) 0.75 Balance 0.50 0.25 0.25
Manganese (Mn) 1 2–4.25 - - -
Molybdenum (Mo) 5–7 2–3 - - -
Nickel (Ni) 0.50 9.0–11.0 - - -
Niobium (Nb) - 0.25–0.8 0.015 6.50–7.50 -
Nitrogen (N) 0.25 0.25–0.5 0.15 0.05 0.05
Oxygen (O) - - 0.40 0.20 0.13
Tantalum (Ta) - - Balance 0.50 -
Titanium (Ti) 0.10 - - Balance Balance
Tungsten (W) 0.20 - - - -
Vanadium (V) - - - - 3.5–4.5
In this study implants with different fixation strategies was used i.e. cemented implants and
different surface treatments for optimizing stability and osseointegration. Metal release and implant
performance is highly dependent on the micro/nano topography of the implant surface [57,58].
Cemented implants have been proved to increased initial stability and minimize micro-motions of
cemented parts leading to long survival rates [59]. The downside of this approach is the possible
formation of a crevice between the cement and implant, which can provide a highly corrosive
environment and lead to accelerated corrosion and subsequently implant failure by AL [60,61]. All
uncemented implants in this study had some form of increased roughness applied to their surfaces for
optimal osseointegration (Table 1). One of the costs of increasing the surface roughness on implant is an
increased functional surface area, which in turn will increase metal release. Especially titanium release
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has recently become a subject of concern and not only in implants used for THRs [62–65]. Another
debated strategy of improving osseointegration is the use of hydroxyapatite (HA) coatings, simulating
the bone chemistry and structure. However, recent studies suggest that the long-term effects are not
improved compared to other porous coatings or rough sandblasted surfaces [66,67].
Patch testing showed a diverse profile of test reactions across all groups making results difficult
to interpret (Table 2). Metals salts are well-known skin irritants and skin reactions may therefore,
in reality, be an irritant rather than an allergic reaction. On the other hand, a positive reaction can
only occur if the metal reaches the viable layers of the epidermis, and this might be a challenge for
some metals [68]. One patient in the AL (+) group had a positive reaction to Cr, which is higher than
expected considering that less than 1% of the general population are allergic to Cr [69]. Surprisingly,
we found positive reactions to Ti (IV) in the control group, which had not been exposed to Ti containing
implants. Although Ti allergy is considered very limited in THRs, in vitro studies of Ti particles suggest
that these can initiate innate and adaptive Th2 cell response [68,70]. Within the field of odontology
there is a growing concern of the innate immune response associated with Ti, which is believed to
cause osteolysis through macrophage secretion of IL1β, IL6, and TNFα [6,71]. A relative high number
of skin reactions to V were observed, although most of these were scored as doubtful, true allergy
cannot be ruled out. While larger cohort studies have found an increased prevalence of metal allergy
in THR patients our study was not powered to examine a possible association [21,72]. Nonetheless,
our findings indicate that metal allergy, as tested by patch test, is not likely to be a key driver of AL in
most patients.
5. Conclusions
Aseptic loosening of implants is a complex tissue response influenced by various factors. Metal
release from implants may generate DTH response capable of accelerating aseptic loosening of implants.
In this study, we report a distinct cytokine profile in periimplant tissues between patients with implant
failure due to AL, compared to mechanical causes, with statistically significant increased levels of
IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, GM-CSF, IFN-γ and TNF-α. In addition, raised metal concentrations
were found in blood and periimplant tissue from patients with failed THRs. Despite these observations,
we failed to detect any correlation between the prevalence of metal allergy and failed THRs or AL.
This work contributes to a better understanding of the immunologic nature of aseptic loosening and
suggests that the immunological events involved in AL are of both innate and adaptive character.
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